Ferrari, Vittorio Domenico
 Distribuzione geografica
Continente #
NA - Nord America 1.867
AS - Asia 835
EU - Europa 689
SA - Sud America 164
AF - Africa 14
OC - Oceania 4
Totale 3.573
Nazione #
US - Stati Uniti d'America 1.840
SG - Singapore 288
CN - Cina 247
BR - Brasile 130
DE - Germania 127
HK - Hong Kong 111
PL - Polonia 107
UA - Ucraina 107
IT - Italia 79
VN - Vietnam 65
FI - Finlandia 63
RU - Federazione Russa 51
GB - Regno Unito 44
IN - India 32
TR - Turchia 31
IE - Irlanda 25
SE - Svezia 18
FR - Francia 16
ES - Italia 14
AR - Argentina 13
BD - Bangladesh 12
MX - Messico 12
CA - Canada 11
BE - Belgio 9
ZA - Sudafrica 9
EC - Ecuador 7
IQ - Iraq 7
AT - Austria 6
CZ - Repubblica Ceca 6
JP - Giappone 6
NL - Olanda 6
PE - Perù 6
ID - Indonesia 5
PK - Pakistan 5
AU - Australia 4
PT - Portogallo 4
TW - Taiwan 4
IR - Iran 3
AZ - Azerbaigian 2
CR - Costa Rica 2
EG - Egitto 2
KZ - Kazakistan 2
LV - Lettonia 2
NP - Nepal 2
PA - Panama 2
TH - Thailandia 2
UY - Uruguay 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
GR - Grecia 1
GY - Guiana 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
MU - Mauritius 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
SA - Arabia Saudita 1
VE - Venezuela 1
Totale 3.573
Città #
Fairfield 192
Ashburn 173
Woodbridge 121
Singapore 111
Warsaw 107
Hong Kong 103
Houston 95
Jacksonville 83
Cambridge 78
Seattle 71
Ann Arbor 69
Wilmington 69
Los Angeles 65
Dallas 58
Chicago 57
Chandler 54
Beijing 53
New York 52
Dearborn 45
Princeton 44
Helsinki 32
Dublin 25
Istanbul 25
Buffalo 23
Ho Chi Minh City 23
Nanjing 22
Salt Lake City 22
Munich 20
Turku 20
The Dalles 19
Redondo Beach 14
Shanghai 14
Boardman 13
Moscow 13
Elk Grove Village 12
Hanoi 12
Secaucus 12
São Paulo 12
San Francisco 11
Tampa 11
Nanchang 10
Des Moines 9
Brescia 8
Brussels 8
Changsha 8
Dong Ket 8
Guangzhou 8
Lancaster 8
Santa Clara 8
Washington 8
Dhaka 7
Rio de Janeiro 7
San Diego 7
Zaragoza 7
Brno 6
Dulles 6
Hebei 6
Kunming 6
Leawood 6
Milan 6
Phoenix 6
Haikou 5
Jinan 5
London 5
New Delhi 5
Salò 5
Shenyang 5
Sterling 5
Tianjin 5
Tokyo 5
Turin 5
Denver 4
Haiphong 4
Hangzhou 4
Jakarta 4
Johannesburg 4
Lima 4
Lisbon 4
Nürnberg 4
Poplar 4
Rovato 4
San Mateo 4
Santo André 4
Stockholm 4
West Jordan 4
Agawam 3
Ardabil 3
Augusta 3
Baghdad 3
Bengaluru 3
Biên Hòa 3
Boston 3
Campinas 3
Charlotte 3
Chiswick 3
Dalmine 3
Detroit 3
Hefei 3
Madrid 3
Montreal 3
Totale 2.359
Nome #
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 361
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 232
Eight‐week interval in flushing and locking port‐a‐cath in cancer patients: A single‐institution experience and systematic review 231
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 198
Primary Ewing's sarcoma of the sinonasal tract in adults: A challenging disease 190
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis 167
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 157
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 155
Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer? 153
Gonadal function in male patients with metastatic renal cell cancer treated with sunitinib: Effects of testosterone replacement on quality of life. 148
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 140
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial 136
Singular coexistence of anti-Hu syndrome, finger clubbing and pseudoscleroderma in small cell lung cancer. 124
Efficacy of topic steroids in the management of asthma and chronic obstructive pulmonary disease in advanced non-small cell lung cancer patients during treatment with nivolumab 109
Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients? 103
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 101
Excavated Lung Metastases In Metastatic Rcc (mrcc): Pseudoprogression As A Response To Sunitinib 98
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial 95
Should everolimus be stopped after radiological progression in metastatic insulinoma? A “cons” point of view 92
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 88
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 84
Trapianto di midollo osseo nei linfomi linfoblastici e nel linfoma di Hodgkin dopo FTBI ed HD-ARAC 83
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 80
Maintenance everolimus beyond progression in pancreatic NET to control insulinoma syndrome 72
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 67
Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma 62
Trapianto di midollo osseo nelle leucemie acute mieloidi in RC. 56
null 51
Totale 3.633
Categoria #
all - tutte 16.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.213


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021270 0 0 0 0 0 41 11 52 37 51 46 32
2021/2022197 17 24 4 6 1 20 4 14 14 29 16 48
2022/2023165 27 7 10 7 12 42 0 11 29 1 3 16
2023/2024295 13 8 33 15 18 52 6 22 63 9 7 49
2024/2025813 9 14 6 92 68 35 49 22 104 34 312 68
2025/2026786 109 174 140 159 147 57 0 0 0 0 0 0
Totale 3.633